187 related articles for article (PubMed ID: 15019535)
21. Protective effect of fluvastatin on degradation of apolipoprotein B by a radical reaction in human plasma.
Aoki S; Ikeda K; Yamamura M; Kojo S
Biol Pharm Bull; 2001 Feb; 24(2):123-6. PubMed ID: 11217077
[TBL] [Abstract][Full Text] [Related]
22. [Early intervention on atherosclerosis by fluvastatin and lectin-like oxidized low-density lipoprotein receptor-1 expression in atherosclerotic arteries in immature rabbits].
Yu YH; Wang Y; Chen Y; Liu ZZ; Sun SZ; Meng XH
Zhonghua Er Ke Za Zhi; 2005 Oct; 43(10):762-6. PubMed ID: 16255856
[TBL] [Abstract][Full Text] [Related]
23. Preservation of endothelial function by the HMG-CoA reductase inhibitor fluvastatin through its lipid-lowering independent antioxidant properties in atherosclerotic rabbits.
Mitani H; Egashira K; Ohashi N; Yoshikawa M; Niwa S; Nonomura K; Nakashima A; Kimura M
Pharmacology; 2003 Jul; 68(3):121-30. PubMed ID: 12784083
[TBL] [Abstract][Full Text] [Related]
24. Antioxidants decreases the intensification of low density lipoprotein in vivo peroxidation during therapy with statins.
Lankin VZ; Tikhaze AK; Kukharchuk VV; Konovalova GG; Pisarenko OI; Kaminnyi AI; Shumaev KB; Belenkov YN
Mol Cell Biochem; 2003 Jul; 249(1-2):129-40. PubMed ID: 12956408
[TBL] [Abstract][Full Text] [Related]
25. Effects of fluvastatin and its major metabolites on low-density lipoprotein oxidation and cholesterol esterification in macrophages.
Tanaka K; Yasuhara M; Suzumura K; Narita H; Suzuki T
Jpn J Pharmacol; 2001 Jul; 86(3):289-96. PubMed ID: 11488428
[TBL] [Abstract][Full Text] [Related]
26. Fluvastatin increases LDL particle size and reduces oxidative stress in patients with hyperlipidemia.
Yoshino G; Hirano T; Kazumi T; Takemoto M; Ohashi N
J Atheroscler Thromb; 2003; 10(6):343-7. PubMed ID: 15037823
[TBL] [Abstract][Full Text] [Related]
27. Fluvastatin ameliorates the hyperhomocysteinemia-induced endothelial dysfunction: the antioxidative properties of fluvastatin.
Morita H; Saito Y; Ohashi N; Yoshikawa M; Katoh M; Ashida T; Kurihara H; Nakamura T; Kurabayashi M; Nagai R
Circ J; 2005 Apr; 69(4):475-80. PubMed ID: 15791046
[TBL] [Abstract][Full Text] [Related]
28. The protective effect of fluvastatin on hydroxyl radical generation by inhibiting low-density lipoprotein (LDL) oxidation in the rat myocardium.
Obata T; Yonemoti H; Aomine M
Microvasc Res; 2009 Mar; 77(2):163-5. PubMed ID: 18840452
[TBL] [Abstract][Full Text] [Related]
29. Fluvastatin normalizes the decreased turnovers of glutathione and ascorbic acid in Watanabe heritable hyperlipidaemic rabbits.
Suzumura K; Kasahara E; Ohnishi Y; Chien KC; Inoue M
Clin Exp Pharmacol Physiol; 2000 Sep; 27(9):709-14. PubMed ID: 10972538
[TBL] [Abstract][Full Text] [Related]
30. Fluvastatin depresses the enhanced lipid peroxidation in vitamin E-deficient hamsters.
Suzumura K; Ohashi N; Oka K; Yasuhara M; Narita H
Free Radic Res; 2001 Dec; 35(6):815-23. PubMed ID: 11811532
[TBL] [Abstract][Full Text] [Related]
31. Cardioprotective effect of fluvastatin on isoproterenol-induced myocardial infarction in rat.
Zhou R; Xu Q; Zheng P; Yan L; Zheng J; Dai G
Eur J Pharmacol; 2008 May; 586(1-3):244-50. PubMed ID: 18384769
[TBL] [Abstract][Full Text] [Related]
32. Cigarette smoke extract inhibits oxidative modification of low density lipoprotein.
Chen C; Loo G
Atherosclerosis; 1995 Jan; 112(2):177-85. PubMed ID: 7772077
[TBL] [Abstract][Full Text] [Related]
33. Protective effect of fluvastatin, a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on MPP(+)-induced hydroxyl radical in the rat striatum.
Obata T; Yamanaka Y
Brain Res; 2000 Mar; 860(1-2):166-9. PubMed ID: 10727637
[TBL] [Abstract][Full Text] [Related]
34. Atherosclerosis and cardiovascular disease in systemic lupus erythematosus: effects of in vivo statin treatment.
Ruiz-Limon P; Barbarroja N; Perez-Sanchez C; Aguirre MA; Bertolaccini ML; Khamashta MA; Rodriguez-Ariza A; Almadén Y; Segui P; Khraiwesh H; Gonzalez-Reyes JA; Villalba JM; Collantes-Estevez E; Cuadrado MJ; Lopez-Pedrera C
Ann Rheum Dis; 2015 Jul; 74(7):1450-8. PubMed ID: 24658835
[TBL] [Abstract][Full Text] [Related]
35. Effect of fluvastatin sodium (XU62-320), a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on the induction of low-density lipoprotein receptor in HepG2 cells.
Hayashi K; Kurokawa J; Nomura S; Kuga Y; Ohkura Y; Kajiyama G
Biochim Biophys Acta; 1993 Apr; 1167(2):223-5. PubMed ID: 8466953
[TBL] [Abstract][Full Text] [Related]
36. Antioxidative effects of fluvastatin and its metabolites against DNA damage in streptozotocin-treated mice.
Imaeda A; Kaneko T; Aoki T; Kondo Y; Nakamura N; Nagase H; Yoshikawa T
Food Chem Toxicol; 2002 Oct; 40(10):1415-22. PubMed ID: 12387303
[TBL] [Abstract][Full Text] [Related]
37. Effect of fluvastatin on plasma apolipoprotein-B-containing particles, including lipoprotein(a). European Fluvastatin Study Group.
Dallongeville J; Fruchart JC; Pfister P; Bard JM
J Intern Med Suppl; 1994; 736():95-101. PubMed ID: 7986315
[TBL] [Abstract][Full Text] [Related]
38. Oxidants in the gas phase of cigarette smoke pass through the lung alveolar wall and raise systemic oxidative stress.
Yamaguchi Y; Nasu F; Harada A; Kunitomo M
J Pharmacol Sci; 2007 Mar; 103(3):275-82. PubMed ID: 17332694
[TBL] [Abstract][Full Text] [Related]
39. An in vitro study of the hydroxyl radical scavenging property of fluvastatin, and HMG-CoA reductase inhibitor.
Suzumura K; Yasuhara M; Tanaka K; Odawara A; Narita H; Suzuki T
Chem Pharm Bull (Tokyo); 1999 Jul; 47(7):1010-2. PubMed ID: 10434403
[TBL] [Abstract][Full Text] [Related]
40. Fluvastatin prevents oxidized low-density lipoprotein-induced injury of renal tubular epithelial cells by inhibiting the phosphatidylinositol 3-kinase/Akt-signaling pathway.
Chu G; Jia R; Yang D
J Nephrol; 2006; 19(3):286-95. PubMed ID: 16874687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
